Literature DB >> 23261573

Rhamnolipid (RL) from Pseudomonas aeruginosa OBP1: a novel chemotaxis and antibacterial agent.

P Bharali1, J P Saikia, A Ray, B K Konwar.   

Abstract

In the present study, the interaction of rhamnolipid produced by Pseudomonas aeruginosa OBP1 with the cell surfaces of Staphylococcus aureus (MTCC 3160) and Klebsiella pneumoniae (MTCC 618) were studied. Rhamnolipid concentration below critical micelle concentration (CMC) did not exhibit significant antibacterial activity. However, on increasing rhamnolipid concentration beyond CMC a prominent antibacterial activity was observed. The results demonstrated different degree of rhamnolipid interaction with both the bacteria. This might be due to the changes in their cell wall composition. The antibacterial activity determined by minimum inhibitory concentration (MIC). The antibacterial activity is prominent within 30 min of incubation. The antibacterial property of rhamnolipid was effective in all tested pH levels (5-9). The rhamnolipid was effective in almost all tested pH levels and showed better chemoattractant property against both the tested bacteria in comparison to glucose. The increase in the membrane permeability was evidenced by increase in the release of protein, enhancement in cell surface hydrophobicity and raises in the retention of crystal violet dye. Further, leakage of 260 nm absorbing intracellular materials, fourier transform infrared spectroscopy (FTIR) and scanning electron microscopy (SEM) analysis confirmed the disruptive action of rhamnolipid. The above evidences support the idea that rhamnolipid significantly alters the cell membrane/envelop that leads to cell damage and enhances membrane permeability. Such activity of rhamnolipid could be used as an additive in the formulation of antibiotic and other antimicrobial agents for enhancing the effectiveness of chemotherapeutics.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23261573     DOI: 10.1016/j.colsurfb.2012.10.064

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  17 in total

1.  Interference Competition Among Household Strains of Pseudomonas.

Authors:  Michael T France; Susanna K Remold
Journal:  Microb Ecol       Date:  2015-08-16       Impact factor: 4.552

2.  Enterococcus faecalis Antagonizes Pseudomonas aeruginosa Growth in Mixed-Species Interactions.

Authors:  Casandra Ai Zhu Tan; Ling Ning Lam; Goran Biukovic; Eliza Ye-Chen Soh; Xiao Wei Toh; José A Lemos; Kimberly A Kline
Journal:  J Bacteriol       Date:  2022-06-27       Impact factor: 3.476

3.  Rhamnolipid Nano-Micelles versus Alcohol-Based Hand Sanitizer: A Comparative Study for Antibacterial Activity against Hospital-Acquired Infections and Toxicity Concerns.

Authors:  Yasmin Abo-Zeid; Marwa Reda Bakkar; Gehad E Elkhouly; Nermeen R Raya; Dalia Zaafar
Journal:  Antibiotics (Basel)       Date:  2022-04-29

4.  Interbacterial Antagonism Mediated by a Released Polysaccharide.

Authors:  Yiwei Liu; Erin S Gloag; Preston J Hill; Matthew R Parsek; Daniel J Wozniak
Journal:  J Bacteriol       Date:  2022-04-21       Impact factor: 3.476

5.  Exogenous Alginate Protects Staphylococcus aureus from Killing by Pseudomonas aeruginosa.

Authors:  Courtney E Price; Dustin G Brown; Dominique H Limoli; Vanessa V Phelan; George A O'Toole
Journal:  J Bacteriol       Date:  2020-03-26       Impact factor: 3.490

6.  Microemulsion synthesis of silver nanoparticles using biosurfactant extracted from Pseudomonas aeruginosa MKVIT3 strain and comparison of their antimicrobial and cytotoxic activities.

Authors:  Moonjit Das; Kaustuvmani Patowary; Radhakrishnan Vidya; Himaja Malipeddi
Journal:  IET Nanobiotechnol       Date:  2016-12       Impact factor: 1.847

7.  Metabolic pathway for a new strain Pseudomonas synxantha LSH-7': from chemotaxis to uptake of n-hexadecane.

Authors:  Long Meng; Haoshuai Li; Mutai Bao; Peiyan Sun
Journal:  Sci Rep       Date:  2017-01-04       Impact factor: 4.379

8.  Pseudomonas aeruginosa exoproducts determine antibiotic efficacy against Staphylococcus aureus.

Authors:  Lauren Radlinski; Sarah E Rowe; Laurel B Kartchner; Robert Maile; Bruce A Cairns; Nicholas P Vitko; Cindy J Gode; Anne M Lachiewicz; Matthew C Wolfgang; Brian P Conlon
Journal:  PLoS Biol       Date:  2017-11-27       Impact factor: 8.029

9.  Rhamnolipids Nano-Micelles as a Potential Hand Sanitizer.

Authors:  Marwa Reda Bakkar; Ahmed Hassan Ibrahim Faraag; Elham R S Soliman; Manar S Fouda; Amir Mahfouz Mokhtar Sarguos; Gary R McLean; Ali M S Hebishy; Gehad E Elkhouly; Nermeen R Raya; Yasmin Abo-Zeid
Journal:  Antibiotics (Basel)       Date:  2021-06-22

10.  Antimicrobial Activity of Monoramnholipids Produced by Bacterial Strains Isolated from the Ross Sea (Antarctica).

Authors:  Pietro Tedesco; Isabel Maida; Fortunato Palma Esposito; Emiliana Tortorella; Karolina Subko; Chidinma Christiana Ezeofor; Ying Zhang; Jioji Tabudravu; Marcel Jaspars; Renato Fani; Donatella de Pascale
Journal:  Mar Drugs       Date:  2016-04-26       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.